Qiang Chen
Direktor/Vorstandsmitglied bei CHINA HAISUM ENGINEERING CO., LTD.
Profil
Qiang Chen currently works at China Haisum Engineering Co., Ltd., as Independent Director from 2023, Jiangsu Huachang Chemical Co., Ltd., as Independent Director from 2023, and Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd., as Independent Director from 2022.
Aktive Positionen von Qiang Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| CHINA HAISUM ENGINEERING CO., LTD. | Direktor/Vorstandsmitglied | 18.05.2023 |
| JIANGSU HUACHANG CHEMICAL CO., LTD | Direktor/Vorstandsmitglied | 22.08.2023 |
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
 Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Air Freight/CouriersTransportation Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.01.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CHINA HAISUM ENGINEERING CO., LTD. | Industrial Services |
| JIANGSU HUACHANG CHEMICAL CO., LTD | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Air Freight/CouriersTransportation Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China. | Transportation |
